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Dependence of Deodorant Usage on ABCC11
Genotype: Scope for Personalized Genetics in
Personal Hygiene
Santiago Rodriguez1, Colin D. Steer2, Alexandra Farrow3, Jean Golding2 and Ian N.M. Day1
Earwax type and axillary odor are genetically determined by rs17822931, a single-nucleotide polymorphism (SNP)
located in the ABCC11 gene. The literature has been concerned with the Mendelian trait of earwax, although
axillary odor is also Mendelian. Ethnic diversity in rs17822931 exists, with higher frequency of allele A in east
Asians. Influence on deodorant usage has not been investigated. In this work, we present a detailed analysis of
the rs17822931 effect on deodorant usage in a large (NB17,000 individuals) population cohort (the Avon
Longitudinal Study of Parents and Children (ALSPAC)). We found strong evidence (P¼ 3.7 10 20) indicating
differential deodorant usage according to the rs17822931 genotype. AA homozygotes were almost 5-fold
overrepresented in categories of never using deodorant or using it infrequently. However, 77.8% of white
European genotypically nonodorous individuals still used deodorant, and 4.7% genotypically odorous individuals
did not. We provide evidence of a behavioral effect associated with rs17822931. This effect has a biological basis
that can result in a change in the family’s environment if an aerosol deodorant is used. It also indicates potential
cost saving to the nonodorous and scope for personalized genetics usage in personal hygiene choices, with
consequent reduction of inappropriate chemical exposures for some.
Journal of Investigative Dermatology (2013) 133, 1760–1767; doi:10.1038/jid.2012.480; published online 17 January 2013
INTRODUCTION
The ABCC11 gene encodes the multidrug resistance protein 8
(MRP8) (Kruh et al., 2007). Although historically identified as a
drug resistance factor, this protein is involved in transport of
many small molecules in normal physiology, in a variety of
cellular and biological contexts. There is strong evidence
suggesting that genetic variation at ABCC11 has pleiotropic
effects. In particular, a functional nonsynonymous single-
nucleotide polymorphism (SNP; rs17822931), also known as
538 G-A or G180R, determines human earwax type
(Yoshiura et al., 2006) and axillary osmidrosis (Nakano
et al., 2009; Martin et al., 2010) and is associated with
apocrine colostrum secretion from the mammary gland
(Miura et al., 2007). It has also been related to breast cancer
risk, although this is more controversial (see Toyoda and
Ishikawa, 2010, and references therein).
The rs17822931 genotype AA determines dry earwax type,
whereas the presence of at least one G allele (GA or GG)
determines wet earwax type in a dominant manner. There are
marked differences in rs17822931 allele frequencies across
ethnic groups (Yoshiura et al., 2006; Toyoda et al., 2009;
Toyoda and Ishikawa, 2010). There is a higher frequency of
the A allele in east Asians, and therefore higher prevalence of
the dry earwax type. In contrast, the wet earwax type is more
prevalent in European and African populations because of
higher frequencies of the G allele.
There is a close histological and functional relationship
between ceruminous and apocrine sweat glands. This relation-
ship is believed to explain the connection between earwax
and axillary odor (Martin et al., 2010). AA homozygous
individuals for rs17822931 display a few of the
characteristic axillary odorants (Martin et al., 2010; Preti and
Leyden, 2010). In contrast, a study of Japanese individuals
showed that essentially all individuals with axillary osmidrosis
were GG or AG for rs17822931 (Nakano et al., 2009). This
indicates that the G allele is necessary and sufficient to cause
axillary odor, whereas the AA genotype effectively marks
nonodorous individuals.
There is strong evidence supporting the fact that the
production of odor associated with rs17822931 follows a
dimorphic pattern. It is necessary to have a functional allele
(rs17822931 G) in order to secrete amino acid conjugates of
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human-specific odorants that lead to the production of axillary
odor (Martin et al., 2010).
Several studies have addressed various biological aspects of
ABCC11 rs17822931, including the possible mechanism of
action and pharmacogenomic aspects (Toyoda et al., 2009;
Toyoda and Ishikawa, 2010). However, behavioral aspects
related to this genetic polymorphism have been studied to a
small extent. In this work, we analyzed the association
between ABCC11 rs17822931 and deodorant usage from a
large sample of unrelated children and their parents from the
Avon Longitudinal Study of Parents and Children (ALSPAC)
(Boyd et al., 2012; Fraser et al., 2012).
RESULTS
No significant deviation from Hardy–Weinberg proportions
was found for rs17822931 for white mothers (w2¼ 2.3,
P¼0.129) or for white children (w2¼0.55, P¼ 0.458). The
analysis of ascertainment bias in rs17822931 (Supplementary
Figure S1 online) showed a slight but nonsignificant
(P¼ 0.129) excess of rs17822931 AA homozygotes (115
expected vs. 134 observed), again indicating that genotyping
error or unrecognized subdivision through admixture or
stratification was not an issue in our analyses. Minor allele
frequencies were 12.5% for white mothers and 24.9% for non-
white mothers. Similar results were observed for the child
genotype: 12.7% (white parentage), 15.1% (mixed parentage),
and 20.7% (non-white parentage). Average usage of deodor-
ants was 6.1 times per week for mothers (SD¼1.90) and 5.2
times per week for partners (SD¼ 2.53). There was lower
usage among non-white parents by 10–16% (Po0.001).
We describe below a summary of the observed results for
nonexperts in statistics. A more detailed description of the
results, including specific statistical evidence supporting our
findings, can be seen in Supplementary Appendix S1.
Regression analyses
We observed a strong association between deodorant usage
and maternal rs17822931 genotype in ALSPAC for both white
and non-white participants. The association was highly sig-
nificant for white mothers (P¼1.8 10 14) and for non-white
mothers (P¼1.5106; Table 1).
However, there was no association between maternal
genotype and partners’ deodorant usage in whites
(P¼ 0.9040). The rs17822931 genotype in children associated
with similar effect sizes for deodorant usage by the mother and
by the partner. When considering white individuals, the
rs17822931 genotype of the child associated significantly
with maternal deodorant usage (P¼0.0004) and with the
use of deodorant by the partner (P¼0.0235).
Five other putative confounders were considered in linear
regression analysis of maternal deodorant use on maternal
genotype (Table 2). Significant associations were observed for
four of them (maternal age, maternal education, housing
tenure, and hygiene), with no significant effect for paternal
social class. The relative effect of the rs17822931
genotype was larger than the effect of each of these variables.
The greater effect ranged from 3 times higher than hygiene to
34 times higher than maternal education, as measured
by the b-coefficients observed in linear regression analyses
(Table 2).
Results from contingency tables
Results from contingency tables (Table 3) allow the identifica-
tion of more specific effects for each of the categories of
deodorant usage in relation to rs17822931. The results for
deodorant usage in four combinations of individuals were as
follows.
Maternal genotype association with maternal deodorant
usage. Table 3a shows that there is a significantly higher
than expected frequency of the AA genotype in white mothers
with a lower use of deodorant. There is a nearly a 5-fold
overrepresentation of AA individuals in the deodorant never use
group, with significant overrepresentations in all other categories
except in the category of daily deodorant usage. In this category,
the observed frequency of AA homozygotes is significantly
lower than that expected. Overall, there is a significant
(P¼ 3.7 10 20) difference between the observed and the
expected numbers in the contingency table for deodorant
usage and the rs17822931 genotype. These results are
for the additive model. They are very similar to the results
observed under the recessive model (Supplementary Table S1
online).
Figure 1 shows the relationship between rs17822931 genotypes
and both an odoriferous steroid (data from Martin et al., 2010)
and deodorant usage. AA homozygotes (with the lowest
production of the odoriferous steroid) showed the highest ratio
of never use over daily deodorant use. The converse was found
for GG homozygotes. AG heterozygotes showed differences in
relation to GG homozygotes, with both lower production of the
odoriferous steroid and significantly (P¼ 0.002) higher ratio of
never use over daily deodorant use than GG homozygotes.
Child genotype association with maternal deodorant usage. The
results from the contingency table analyzing white
children’s rs17822931 genotype by maternal deodorant usage
(Table 3b and Supplementary Table S2 online) are different from
the results observed in white mothers. There is an increased
proportion of children with AA and GA genotypes in the category
of never use of deodorant in white mothers. However, this
increase is not as important as the one observed in deodorant
usage of white mothers according to their own rs17822931
genotype. Overall, there is a significant (P¼ 0.010) difference
between the observed and expected frequencies under the
additive model (Table 3b), although these differences are not
significant (P¼ 0.173) under the recessive model (Supplementary
Table S2 online).
Child genotype association with partner’s deodorant
usage. Table 3c and Supplementary Table S3 online show
partner’s deodorant usage according to children’s rs17822931
genotype. No significant differences were observed in the con-
tingency tests either under the additive model (P¼ 0.170) or
under the recessive model (P¼ 0.263).
Maternal genotype association with partner’s deodorant usage.
Similar results were observed for the analyses of partner’s
deodorant usage stratified by maternal rs17822931 genotype
(Supplementary Tables S4 and S5 online).
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Prediction of parental deodorant usage on the basis of the child’s
genotype
Supplementary Figure S2 online shows the expected child
genotype–parent phenotype associations based on parents’
genotypes, allele frequency, and proportions of never use over
daily use of deodorant for each genotypic category, assuming
a recessive model and restricting to white mothers. For
maternal genotype–phenotype associations, we found good
agreement between the observed ratios in children for each
genotype and the liability predictions computed from parents.
Percentage of deodorant usage: mothers versus partners
The percentage of ALSPAC partners using deodorant daily or
on most days (82.7%) is significantly lower (P¼5.3 1074)
than the percentage for mothers using deodorant daily or on
most days (93.3%). The figures are computed from Table 3
and are as follows: 945 partners using deodorant approxi-
mately once a week or less and 4,502 partners using it on
most days or daily; and 433 mothers using deodorant about
once a week or less and 6,062 mothers using it on most days
or daily.
Table 3a shows that 77.8% of women with the AA genotype
still use deodorant (at least once a week week), compared
with 80.0% of male parents of children with the AA genotype
who use deodorant at least once a week (Table 3c).
Table 3a also shows that the proportion of women with the
GG genotype who do not use deodorant (o1 per week or
never) is much reduced (4.7%) compared with 13.0% of male
parents of children with the GG genotype who never use
deodorant or use it o1 per week (Table 3c).
The results in non-white ALSPAC participants can be seen in
Supplementary Appendix S1.
DISCUSSION
This study shows a significant association between deodorant
usage and a common genetic variation at the DNA level,
which to our knowledge is previously unreported. Homozy-
gotes for the rs17822931 A allele within ABCC11 are almost
5-fold less likely to use deodorant than GG homozygotes and
heterozygotes for this SNP. Previous studies offer a biological
basis for this association. Homozygotes for the rs17822931 A
allele show clearcut differences compared with G allele
carriers in the content of axillary secretions (Martin et al.,
2010; Preti and Leyden, 2010). The lower frequency of
deodorant usage in this group of individuals therefore
reflects the lack of need for deodorant usage, a substantially
socially determined behavior. Figure 2 shows a diagram
relating rs17822931 genotype with axillary odor and deodor-
ant usage.
Nonodorous mothers and partners still use deodorant
On the basis of the production of axillary odorants, we
would expect that AA individuals would not use
deodorant, whereas GG individuals would use it. However,
there are mothers who use deodorant at least once a
week without needing it (77.8% of women with the AA
genotype). From child genotype, we estimate that 80.0% of
fathers of AA genotype children use deodorant with less need
to do so.
Deodorant nonuse in the genotypically odorous
In addition, our results indicate a different behavior between
men and women in relation to not using deodorant. This
seems to be dependent on the rs17822931 genotype. The
proportion of women with the GG genotype who, despite
needing deodorant, never use it or use it less than once a week
is small (4.7%). In contrast, 13.0% of fathers of children with
the GG genotype who need to use a deodorant never use it.
Implications
This indicates the influence of other factors such as sex on the
behavior of deodorant usage. In northeast Asia, an estimated
7% of individuals use deodorant (Air Sense News, 2008),
whereaso1% of individuals are of the GG genotype (dbSNP,
2011). If, as in our UK study, 77.8% of AA genotype women
used deodorant, then the total usage would be at least
62–74%. This indicates that sociocultural factors also have a
major impact on deodorant usage. In this instance, it is likely
that deodorant usage is not widely adopted because there is,
for much of the east Asia population, no need for it. The
opposite is true in European populations.
The finding that 77.8% of nonodorous (AA) individuals use
deodorant at least once a week makes rs17822931 a potential
target for personal genomics in relation to deodorant usage.
These individuals could avoid the chemical exposures, der-
matological (Zirwas and Moennich, 2008) or other health risks
Table 2. Linear regression analysis of maternal
deodorant use on maternal genotype (recessive model)
adjusted for five confounders (N¼ 4,903)
B
95%
Confidence
interval P-value
Group
P-value
Maternal 25–29 0.06  0.22 0.10 0.475
age 30þ 0.41  0.57 0.24 1.7 10 6 2.6 10 10
Maternal Medium 0.05  0.09 0.19 0.472
education High 0.23  0.37 0.09 0.002 2.3105
Social III 0.02  0.09 0.14 0.679
class IVþV 0.03  0.21 0.14 0.705 0.776
Housing Council 0.26  0.46 0.05 0.013
tenure Other 0.36  0.55 0.17 2.2 10 4 1.5104
Hygiene Medium 0.40 0.28 0.53 2.31010
High 0.57 0.44 0.70 2.11018 4.1 10 18
Genotype AA 1.69  2.08 1.30 2.11017
Hygiene of the mother and partner was estimated in two different ways. For
the mother, how often she washed the child (face, hands, and body) was
considered, whereas for the partner how often he helped with washing
clothes, dinnerware, and utensils was considered. No data were available
on how often the parents washed themselves. Reference categories were as
follows:o25 for maternal age, low education, paternal social classes Iþ II,
mortgaged/owned, low hygiene, and GGþGA for maternal genotype.
Group P-values represent a 2 d.f. statistic testing that both parameters for a
particular confounder were zero. Analysis restricted to mothers of white
ethnic origin.
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(Farrow et al., 2003), and cost without social disadvantage.
We estimate a total unnecessary expenditure of d9million/year
(45104 users spending d20 per year) in this 1% of the UK
population.
Considering the proposed odor-related mate choice related
to the HLA region (Yamazaki and Beauchamp, 2007),
ABCC11 genotype is also a candidate for assortative mating
based on its influence on body odor. However, we found no
association between maternal rs17822931 genotype and
partner’s deodorant usage. It is notable that apparently
subtle HLA-related genetic traits may influence mate choice,
whereas the potent axillary effect of ABCC11 does not.
However, social selection at a low rate over many
generations or before the advent of deodorants remains
plausible and also a possible mechanism for allelic selection
in populations. Other overt genetically influenced traits such
as hair (Sabeti et al., 2007), skin color, or coat color in animals
(Ludwig et al., 2009), as well as height, are certainly subject to
selection or assortative mating.
Heterozygote effect
Although the recessive model was a better fit than the additive
model to maternal usage with maternal genotype, there was
still a significant deviation reflecting an effect for GA, which
was greater than a recessive effect (equal to GG) but less than
an additive effect. Indeed, we observed small but statistically
significant (P¼ 0.002) differences between rs17822931 GG
and GA individuals in relation to deodorant usage. These
differences mirror the reported differences in concentration of
odorants across rs17822931 genotypes (Martin et al., 2010).
Within rs17822931, fewer GA individuals use deodorants
than GG individuals, consistent with a slightly lower
production of axillary odorants by the former.
Population substructure and self-reported phenotype
Given that there are marked differences in genotype frequen-
cies between white and non-white populations (Yoshiura
et al., 2006; Toyoda et al., 2009; Toyoda and Ishikawa,
2010), one could argue that our results could be due to
population substructure. However, the associations were
equally clearcut when non-white individuals were removed
Table 3. Association of genotype with deodorant usage
GG GA AA
(a)
Never 166 (195.4) 69 (55.0) 20 (4.6)
4.42 3.56 51.67
1 1 1
o1 per week 66 (67.4) 16 (19.0) 6 (1.6)
0.03 0.47 12.30
1 0.58 (0.32–1.08) 0.75 (0.29–1.96)
B1 per week 67 (69.0) 19 (19.4) 4 (1.6)
0.06 0.01 3.49
1 0.68 (0.38–1.22) 0.50 (0.16–1.50)
Most days 608 (650.6) 213 (183.1) 28 (15.3)
2.79 4.87 10.56
1 0.84 (0.61–1.16) 0.38 (0.21–0.70)
Daily 4,070 (3,994.6) 1,084 (1,124.5) 59 (93.9)
1.42 1.46 12.98
1 0.64 (0.48–0.86) 0.12 (0.07–0.20)
w2¼110.07, 8 degrees of freedom, 2-sided P-value¼ 3.71020
(b)
Never 192 (213.5) 80 (61.9) 8 (4.7)
2.16 5.31 2.37
1 1 1
o1 per week 65 (64.8) 20 (18.8) 0 (1.4)
0.00 0.08 1.42
1 0.74 (0.42–1.30) N/A
B1 per week 96 (96.1) 27 (27.8) 3 (2.1)
0.00 0.03 0.38
1 0.68 (0.41–1.11) 0.75 (0.19–2.89)
Most days 667 (696.0) 226 (201.8) 20 (15.2)
1.21 2.91 1.49
1 0.81 (0.60–1.10) 0.72 (0.31–1.66)
Daily 4,417 (4,366.7) 1,223 (1,265.8) 88 (95.6)
0.58 1.44 0.60
1 0.66 (0.51–0.87) 0.48 (0.23–1.00)
w2¼19.98, 8 degrees of freedom, 2-sided P-value¼0.010
(c)
Never 408 (413.2) 120 (119.4) 13 (8.4)
0.06 0.00 2.46
1 1 1
o1 per week 132 (132.1) 37 (38.2) 4 (2.7)
0.00 0.04 0.63
1 0.95 (0.63–1.45) 0.95 (0.30–2.97)
B1 per week 165 (176.4) 65 (51.0) 1 (3.6)
0.74 3.86 1.88
1 1.34 (0.94–1.90) 0.19 (0.02–1.47)
Most days 923 (934.0) 281 (269.9) 19 (19.1)
0.13 0.46 0.00
1 1.04 (0.81–1.32) 0.65 (0.32–1.32)
Table 3 (Continued )
GG GA AA
Daily 2,532 (2,504.3) 299 (723.6) 48 (51.2)
0.31 0.84 0.20
1 0.40 (0.32–0.51) 0.60 (0.32–1.11)
w2¼11.60, 8 degrees of freedom, 2-sided P-value¼0.170
(a) Maternal genotype with maternal deodorant usage. (b) Association of
child’s genotype with maternal deodorant usage. (c) Association of child’s
genotype with partner’s deodorant usage. Contingency table showing
genotypic frequencies of rs17822931 observed in each category of
deodorant usage in white mothers in ALSPAC. Expected numbers are in
brackets and contribution to the overall w2 in italics. Line 3 within each cell
shows the odds ratio and 95% confidence interval (in brackets).
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from the analyses, indicating that the effect attributes to the
genotype and not to population substructure. In addition, our
Hardy–Weinberg results show no significant difference
between the observed and expected frequency of AA homo-
zygotes, with no significant evidence of missingness of this
genotype. This represents additional evidence supporting the
contention that all the observed AA homozygous mothers who
were reported to be white European are indeed white
European, and argues against our results being an artifact
due to population substructure.
Another potential source of confounding is the fact that
deodorant usage is a self-reported phenotype in our study and
in previous studies (Mirick et al., 2002). This opens the
possibility that participants underreported or overreported
deodorant usage. This source of confounding is less likely in
the categories of daily and never use, as these are clearcut. We
do not have a clear indication about the effect in other
categories. To have a significant effect, underreporting or
overreporting would have to involve a differential effect of one
genotype.
In addition, it is possible that a proportion of the self-
reported deodorant usage is actually antiperspirant usage, as
most people think that both deodorants and antiperspirants are
the same thing. However, whereas deodorants reduce body
odor and have an antiseptic action against bacteria, antiper-
spirants reduce the amount of sweat acting on pores
(Benohanian, 2001). The overall result is the same in both
instances (reducing axillary odor), but the fact that both
deodorants and antiperspirants have different mechanisms of
action suggests that they possibly have different biological/
genetic relationships.
However, it is recognized for genetic association studies, in
contrast with other epidemiological association studies, that
genotype cannot be ‘‘caused’’ by outcomes or other factors
(e.g., confounders) and therefore is an independent/orthogonal
factor in such analyses (Smith et al., 2007; Ebrahim and
Davey-Smith, 2008). Supplementary Table S6 online shows
that the rs17822931 genotype distributed randomly relative to
(i.e., not association with) maternal age, maternal education,
paternal social class, housing tenure, and hygiene. We do
observe a strong association of maternal age, maternal
education, housing tenure, and hygiene with deodorant usage,
but genotype is independent of these factors. In addition, on
the basis of the observed magnitude of effects found, our
results are consistent with the relatively larger effect for the
rs17822931 genotype compared with the effects observed for
all putative confounders, including hygiene.
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Figure 1. Relationship between an odoriferous steroid and rs17822931 single-
nucleotide polymorphism (SNP) genotype and between deodorant use and
the rs17822931 SNP genotype. (a) Concentration of the odoriferous steroid 5a-
androst-16-en-3-one observed for each rs17822931 SNP genotype, as
previously described (Martin et al., 2010). (b) Ratio of never use over daily use
of deodorant in ALSPAC (Avon Longitudinal Study of Parents and Children)
white mothers observed for each rs17822931 SNP genotype. *There is a
significant (P¼ 0.002) difference between the ratios observed in AG and GG
individuals.
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Figure 2. Diagram showing the involvement of genetic variation in ABCC11
and both axillary odor and deodorant usage.
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Non-white individuals
We also analyzed deodorant usage in non-white individuals.
In non-whites, we found effects similar to those observed in
UK Europeans. rs17822931 AA homozygotes were less likely
to use deodorant than GA and GG individuals. This is
consistent with the lower production of axillary odorants in
AA homozygotes regardless of their ethnic origin and repre-
sents an extension, to non-whites, of the results observed in
our work in UK Europeans in relation to deodorant usage and
rs17822931. However, these results should be interpreted
with caution, given the small sample size and the possibility of
population substructure within non-whites.
In summary, we have shown that the rs17822931 genotype
is a strong predictor of deodorant usage, but despite
rs17822931 representing a Mendelian trait, B80% of geno-
typically nonodorous white European mothers still use deo-
dorant. The above finding appears to be true for males as well.
This is likely driven by sociocultural factors. On the basis of
genotype (and/or dry earwax), this group could elect to
abandon the chemical exposures and costs of deodorant
use. This represents a potential application of personalized
genetics in personal hygiene.
MATERIALS AND METHODS
Participants
ALSPAC is a longitudinal, population-based birth cohort study that
recruited 14,541 pregnant women residing in Avon, United Kingdom,
with expected dates of delivery between 1 April 1991 and 31
December 1992 (Boyd et al., 2012; Fraser et al., 2012). There were
14,062 live-born children. There is questionnaire information for both
mothers and their partners. Most of the mother’s partners are fathers of
the mother’s children. The study protocol has been described
previously (Jones et al., 2000; Golding et al., 2001), and further
details are available on the ALSPAC website (http://www.bris.ac.uk/
alspac). Ethical approval for all aspects of data collection was
obtained from the ALSPAC Law and Ethics Committee (institutional
review board 00003312). Written informed consent for the study was
obtained for genetic analysis. Our study adhers to the Declaration of
Helsinki Principles.
Genotyping
All ALSPAC mothers and children were genotyped for rs17822931 by
KBiosciences (Essex, UK) with their KASPar system. This is a
competitive allele-specific PCR SNP genotyping system that uses
Fluoresence Resonance Energy Transfer (FRET) quencher cassette
oligos (KBioscience, 2009). A total of 8,326 mothers and 9,167
children were successfully genotyped for rs17822931. Deviations
from Hardy–Weinberg proportions were calculated with the Hardy–
Weinberg equilibrium calculator (http://www.oege.org/software/
hwe-mr-calc.shtml) (Rodriguez et al., 2009). This calculator was
also used to test possible ‘‘missingness’’ (ascertainment bias) of
rs17822931 AA genotypes in white mothers.
Study variables
Deodorant use was assessed by self-completed questionnaires admi-
nistered during pregnancy for the partner and at 8 months after the
child was born for the mother of the study child. Under a section
entitled ‘‘Chemicals in your environment,’’ each mother was asked
the following question: ‘‘In the last few months, how often have you
used the following (whether at home or at work)?’’ There was then a
list of chemicals, including ‘‘deodorants.’’ The partner was asked a
similar set of questions during pregnancy, but they were presented
with the words ‘‘Just before your partner became pregnant, how often
did you use the following (whether at home or at work)?’’ These
questions had categorical responses on a 5-point scale ranging from
not at all to daily. These were converted to an estimate of weekly
usage: not at all (0), less than once a week (0.5), about once a week
(1), most days (4), and daily (7).
The total number of mothers with information for both deodorant
use and rs17822931 were 6,495 and there were 7,132 children. A
total of 5,047 partners had both phenotypic information for deodorant
use and rs17822931 genotypic information for their children.
Statistical analyses
Linear regression was used to analyze the estimated weekly usage.
The results for additive (number of copies of the minor allele) and
recessive (effect of homozygotes of minor allele) genetic models are
reported. Deviations from these models were tested by comparison
with the genotype genetic model.
On the basis of maternal genotype–phenotype associations, we
calculated the expected child genotype–parent phenotype associa-
tions based on the recessive model. These predictions of child’s
rs17822931 genotype were based on parents’ genotypes, allele
frequency, and proportions of never use over daily use of deodorant
for each genotypic category in white mothers. They were computed
as the probability of transmission of each allele multiplied by the
allele frequency and for the ratio of never use over daily use of
deodorant.
The w2 tests for contingency tables were performed with the
software CONTING ver 2.61 (Ott, 1988).
Odds ratios and 95% confidence intervals were computed using
the odds ratio calculator (Bland and Altman, 2000).
Linear regression was performed using Stata version 12.2 (Stata
Corp, College Station, TX).
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